clearli immun weaker econom data throughout
day cc revenu declin stabil key european countri keep
less wors thesi continu near-term send share
ex restructur vs street notabl improv
includ franc flat day cc revenu growth improv
albeit strong februari weaker march oup margin improv
y/i help off-set cice chang us headwind
year saw improv declin vs manag confid
close gap vs market spain improv vs
expect continu improv final acquisit swiss
franchis add annual revenu remain problem area
germany/netherland restructur program
complet aim maintain profit revenu growth return
go forward eas comp set
potenti revenu acceler model howev share
ytd vs think good news price
next leg stock via multipl re-rat come improv macro
clariti across europ clearli increas investor confid find
bottom europ result ntm price-to-earnings re-rat sinc low late
share trade updat ntm ep howev acceler
well understood investor think case multipl re-rat toward
mid-cycl averag lie improv macro data across europ
could drive return hsd growth rate
ultim remain uw continu track macro data europ
work margin opportun follow recent restructur initi
updat estim swiss acquisit rais pt
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
underweight orient european
economi sale tough comp
regulatori chang franc could limit upsid
see case rel under-perform
econom activ europ stabil grow
plu employ recoveri reacceler
scenario ep could higher
assum price-to-earnings multipl upsid scenario
 slow europ growth peak
addit headwind fx could see
ep lower multipl
discount back downsid case
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
new pt base ntm ep prior pt base
estimateconsensu estimatecommentstot result impact weak usd strong improv franc off-set declin northern europ decreas cc organ growth cc organ growth same-day basi cc growth cc exc restructur charg oper profit margin decreas bp excl restructur charg line midpoint guidance- ep cc ep exclud restructur charg impact ep fx impact cent barclay
segment detailsactual/reportedbarclay estimateconsensu y/i decreas cc oup margin increas bp y/i y/i declin cc oup margin increas bpsy/i y/i declin cc y/i y/i decreas cc oup margin decreas bp excl restructur chargesy/i y/i declin cc y/i y/i declin cc driven signific de-lever germani netherland sweden combin tech spendy/i oup margin declin bp y/i decreas cc oup margin decreas bpsy/i y/i decreas cc oup margin decreas bpsy/i europ europ sale cc flat aver daili cc growth europ sale cc aver daili cc growth spain europ sale cc aver daili cc growth europ sale america sale cc aver daili cc growth mexico america sale cc aver daili cc growth canada america sale cc aver daili cc growth america sale cc northern europe- uk europ sale cc germani europ sale cc nordic europ sale cc netherland europ sale cc belgium cc europ cc apme- total sale cc japan apm sale cc australia/nz apm sale cc apm sale flat cc right manag total sale cc driven reduc outplac activ barclay
guidanc provid except epslow-highbarclay research estimatesbarc estim pre guidestreet estim pre-guiderevenu report total southern northern right constant curr total southern northern right profit profit ex barclay
manav patnaik ryan leonard herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli
indirectli relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
